ALC
$68.40
Alcon
($1.57)
(2.24%)
ALC
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  $0.44
Revenue:  $1.88 Bil
Tuesday
May 25
4:20 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, February 23, 2021

What do you expect when ALC reports earnings?
Beat
Meet
Miss

Where is ALC's stock price going from here?
Up
Flat
Down
Stock chart of ALC
Analysts
Summary of analysts' recommendations for ALC
Score
Grade
Pivots
Resistance
$71.41
$70.65
$69.53

$68.77

Support
$67.64
$66.88
$65.76
Tweet
Growth
Description
Alcon AG is specialized in the medical industry. The Company operates mainly as an eye care device company. Its operating segment consists of Surgical and Vision Care. Surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery as well as advanced technology intraocular lenses to treat cataracts and refractive errors, such as presbyopia and astigmatism. It also includes advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery. Vision Care segment manufactures contact lenses and lens care products, such as products for dry eye, contact lens care, ocular allergies as well as ocular vitamins and redness relievers. The Company also offers continuing education for eye care professionals. Alcon AG is based in Geneva, Switzerland.